SLC7A11 and cancer: Correlations between SLC7A11 gene expression and the potency of 1400 anticancer agents over 60 human cancer cell lines revealed 12 as inhibitor and substrate of system Xc− with half maximal inhibitory concentration (IC50) values ranging from 0.86 to 53 μM in different carcinoma cell lines.